Navigation Links
Global Stem Cells Group to Participate in the 15th International Congress of Aesthetic Surgery in Boca del Rio, Veracruz
Date:6/16/2015

MIAMI (PRWEB) June 16, 2015

Charles Mahl, M.D. and David B. Audley will represent Global Stem Cells Group, Inc. as keynote speakers at the 15th International Congress of Aesthetic Surgery in Boca del Rio in Veracruz, Mexico July 9-12, 2015. Mahl, a member of the Global Stem Cells Group Scientific Advisory Board, and Audley, the chairman and general secretary of the Regentech Alliance (RTA), will join more than 1,500 aesthetic surgeons and specialists in the fields of anti-aging and regenerative medicine from around the globe for the four day event.

Hosted by the Instituto de Estudios Superiores en Medicina (Institute of Advanced Studies in Medicine) in Veracruz, conference attendees will include an international lineup of physicians and medical practitioners in a variety of disciplines who will gather to discuss the newest therapies, protocols and innovative procedures available in aesthetic medicine.

Mahl, who maintains an active practice in regenerative medicine, preventive aging and pain therapies, will bring his expertise in prolotherapy, platelet rich plasma injections and stem cell therapies to the conference. Audley is a pioneer in the field of regenerative medicine and the founding executive director of the International Cellular Medicine Society (ICMS), the first professional medical association dedicated to the development of standards and accreditation for medical facilities engaged in cell-based therapies.

The conference will feature workshops in botulinum toxin applications for beginners and advanced students, and peeling treatments for stretch marks. Some of the topics to be addressed at the event include updates in aesthetic surgery, regenerative medicine therapies, platelet rich plasma applications, clinical and therapeutic stem cell applications, facial fillings, COFEPRIS guidelines, legal issues associated with aesthetic surgery and more.

The conference will take place at the Hotel Galerias Plaza Veracruz, Blvd. Adolfo Ruiz Cortines #3495, Costa Verde, Boca Del Río, Veracruz. For more information on the 15th International Congress of Aesthetic Surgery, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com or call 305-224-1858.

About Global Stem Cell Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

About Charles Mahl, M.D.:

Charles F. Mahl, M.D. is a Miami-based specialist in regenerative medicine, preventive aging and pain therapies. His expertise includes prolotherapy, platelet rich plasma injections and stem cell therapies for a variety of painful orthopedic conditions and injuries involving (but not limited to) the back, sacroiliac joints, hips, knees, shoulders and neck. Mahl’s background as a vitreo-retinal surgeon prior to his training in regenerative medicine makes him eminently qualified to perform stem cell therapies on the eyes.

A member of the Global Stem Cells Group Scientific Advisory Board, Mahl sees stem cell therapies as medicine’s new frontier, offering unlimited possibilities for easing and eliminating many forms of disease and injury-related pain. He is licensed to practice medicine in Florida and Board Certified in Integrative Medicine. Mahl has completed multiple fellowships in age management medicine, and spent more than two years in a mentorship program for prolotherapy and regenerative injection medicine with Alvin Stein, M.D., a relationship that continues to this day. For Mahl’s full bio, visit http://www.stemcellsgroup.com/advisory-board/.

About David B. Audley:

David B. Audley serves as the Chair and General Secretary of the Regentech Alliance (RTA), a 501(c)3 backed by individuals and institutions who support the Regentech mission to bring peer oversight and transparency to the field of cell-based and regenerative medicine. Audley is a pioneer in the emerging field of regenerative medicine, and the founding executive director of the International Cellular Medicine Society (ICMS), the first professional medical association dedicated to the development of standards and accreditation for medical facilities engaged in cell-based therapies. Audley has taken a leadership role in drafting international standards and governmental regulations for the Cayman Islands and the Bahamas, and has worked with regulators in Mexico, the Kingdom of Jordan, and China to provide frameworks for physicians. Audley is a well-known lecturer who has spoken widely on varying topics dealing with the trends in patient care, the importance of oversight for investigational therapies, the emergence of regenerative medicine and the global and regulatory issues associated with medical tourism. For more information, visit http://regen-tech.org.

###

Read the full story at http://www.prweb.com/releases/GlobalStemCellsGroup/CongressAestheticSurgery/prweb12790998.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
2. Guidepoint Global Launches Two Major Enhancements to its Client Research Portal
3. Global Regulatory Milestones for Invibio Biomaterial Solutions
4. DuPont Joins Israel’s Office of the Chief Scientist Global Enterprise R&D Cooperation Framework
5. Global Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) - 2013 Market Report
6. Lucintel's Analysis of Global Catalysts Industry: Chemical and Automobile Industries Play Crucial Role in Growth
7. Global Biochips and Microarrays 2013 Market Report
8. Global Bio-implants Market 2012-2016 New Research Report Now Available at MarketResearchReports.biz
9. USP Global Fellowship Awards Program Call for Applications
10. Medical Gases and Equipment Market is Expected to Reach USD 9 Billion Globally in 2018: Transparency Market Research
11. Global Food Safety Testing Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... Oct. 10, 2017 International research firm Parks Associates ... speak at the TMA 2017 Annual Meeting , October 11 in ... the residential home security market and how smart safety and security products ... Parks Associates: Smart ... "The residential security market ...
(Date:10/9/2017)... ... 2017 , ... The award-winning American Farmer television series will feature 3 Bar ... Tuesdays at 8:30aET on RFD-TV. , With global population estimates nearing ten billion ... continue to feed a growing nation. At the same time, many of our valuable ...
(Date:10/7/2017)... Seattle, WA (PRWEB) , ... ... ... the industry leader in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome ... the ProxiMeta Hi-C kit and accompanying cloud-based bioinformatics software to perform Hi-C ...
Breaking Biology Technology:
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
Breaking Biology News(10 mins):